- Home
- INGN
INGN
Inogen Inc
as 03-06-2025 4:00pm EST
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | GOLETA |
| Market Cap: | 247.9M | IPO Year: | 2014 |
| Target Price: | $7.00 | AVG Volume (30 days): | 381.6K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.14 - $13.33 | Next Earning Date: | 02-25-2025 |
| Revenue: | $335,705,000 | Revenue Growth: | 6.35% |
| Revenue Growth (this year): | 6.52% | Revenue Growth (next year): | 0.60% |
Stock Insider Trading Activity of Inogen Inc (INGN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Smith Kevin Raymond Merrill | INGN | CEO and President | Feb 28 '25 | Buy | $8.56 | 11,709 | $100,245.43 | 70,274 | |
| Bourque Michael J. | INGN | EVP, CFO & Treasurer | Feb 28 '25 | Buy | $8.32 | 3,000 | $24,960.00 | 47,646 |
Latest Inogen Inc News
INGN Breaking Stock News: Dive into INGN Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results
Simply Wall St.
8 days ago
Inogen Full Year 2024 Earnings: Beats Expectations
Zacks
8 days ago
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up
Thomson Reuters StreetEvents
9 days ago
Q4 2024 Inogen Inc Earnings Call
GuruFocus.com
9 days ago
Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...
Zacks
9 days ago
Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates
Associated Press Finance
9 days ago
Inogen: Q4 Earnings Snapshot
Business Wire
9 days ago
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
Compare INGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INGN Inogen Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.